StockData
Anixa Biosciences Inc logo

Anixa Biosciences Inc (ANIX) stock

ANIXNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 9, 2026Score 6/30
$2.62−0.06 (-2.24%)

Close on Nov 13, 2026Market cap $91.08MP/E –Yield –

Anixa Biosciences statistics

59 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jul 31, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$91.08M
$272.32M
Enterprise Value
$75.95M
$146.23M
PB Ratio
6.29
2.00
P/TBV Ratio
6.29
2.22

Share statisticsIndustry

Shares Change (QoQ)
1.95%
0.50%
Float
25M
49M
Shares Held by Insiders
28.4%
11.7%
Shares Held by Institutions
15.4%
56.4%

Short sellingIndustry

Short Interest
2M
–
Short Interest Change
-2.00%
-0.80%
Short % of Float
6.54%
9.01%
Short % of Shares Outstanding
4.68%
6.30%
Days to Cover
8.40
5.15

Stock price statisticsIndustry

52-Week High
$5.46
–
52-Week Low
$2.32
–
20-Day Moving Average
$2.98
–
50-Day Moving Average
$2.88
–
200-Day Moving Average
$2.96
–
Average True Range (14)
$0.20
–
Price Change (1 Week)
-17.5%
-1.15%
Price Change (1 Month)
-5.76%
-4.87%
Price Change (3 Months)
-24.9%
-21.0%
Price Change (6 Months)
-7.09%
-20.6%
Price Change (YTD)
-16.0%
-23.6%
Price Change (1 Year)
-40.3%
-22.4%
Price Change (3 Years)
-8.39%
-29.5%
Price Change (5 Years)
-44.0%
-77.9%
Price Change (10 Years)
-50.6%
-65.4%
Average Volume (10 Days)
193,759
–
Average Volume (20 Days)
197,859
–
Average Volume (90 Days)
271,441
–
Relative Volume
1.03
0.70
Relative Strength Index (14)
39.3
43.4
Volatility (1 Year)
66.6%
80.1%
Beta (5 Years)
0.63
1.07

Returns on capitalIndustry

Return on Equity (ROE)
-66.8%
-49.9%
Return on Assets (ROA)
-63.4%
-40.6%
Return on Invested Capital (ROIC)
-1478.4%
-32.9%
Return on Capital Employed (ROCE)
-82.3%
-37.9%

Financial positionIndustry

Current Ratio
8.54
3.30
Quick Ratio
7.94
2.39

EfficiencyIndustry

Profits Per Employee
-$2.60M
-$689.41K
Employee Count
4
74
WACC
8.23%
10.2%

Income statement (TTM)Industry

Operating Income
-$10.98M
-$21.37M
Net Income
-$10.38M
-$22.35M
EBITDA
-$10.98M
-$17.21M

Balance sheetIndustry

Net Cash (Debt)
$13.86M
$17.76M
Net Cash Per Share
$0.40
$0.80
Equity (Book Value)
$14.47M
$53.89M
Book Value Per Share
$0.42
$1.50
Tangible Book Value
$14.47M
$27.13M
Working Capital
$13.17M
$79.99M

Cash flow (TTM)Industry

Operating Cash Flow
-$7.38M
-$12.38M

Dividends and yieldsIndustry

Earnings Yield
-11.4%
-21.8%

Scores and fair valueIndustry

Altman Z-Score
3.73
0.23
Piotroski F-Score
2
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodANIXS&P 500DifferenceANIX per yearS&P 500 per year
1 month-1.9%-3.0%+1.2 pts
3 months-18.1%-2.8%−15.3 pts
Year to date-16.0%+11.5%−27.5 pts
1 year-40.3%+13.5%−53.8 pts
3 years-11.8%+77.7%−89.5 pts-4.1%+21.1%
5 years-44.0%+72.6%−116.6 pts-11.0%+11.5%
10 years-54.8%+308.2%−363.0 pts-7.6%+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

2M ANIX shares were sold short on Oct 30, 2026, down 2.0% from the previous report, or 6.54% of the shares available to trade. At recent volumes it would take 8.4 days to buy them back. Over the last 20 sessions, 50.9% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20261,628,481-2.0%193,7928.4
Oct 15, 20261,661,781+23.1%260,1456.4
Sep 30, 20261,350,212+28.0%366,1813.7
Sep 15, 20261,054,934+6.2%387,4292.7
Aug 31, 2026993,183+1.6%297,8103.3
Aug 14, 2026977,973-10.4%154,7956.3
Jul 31, 20261,090,946+26.5%297,6313.7
Jul 15, 2026862,186-2.7%277,0503.1
Jun 30, 2026885,939+10.3%366,3062.4
Jun 15, 2026803,102-20.8%132,2926.1
May 29, 20261,013,512+3.1%93,64110.8
May 15, 2026983,354-5.1%113,1318.7

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?